COMP <GO>
OGN vs JNJ // REVENUE GROWTH (YOY)
Organon & Co. (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: OGN 3
— JNJ 7
▲ REVENUE GROWTH (YOY) LEADER: JNJ
LAST: $13.84 (+0.22%) • MKT CAP: $3.63B
revenue-growth
-2.90%
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
revenue-growth
6.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OGN VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OGN | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 53.30% | 67.90% | -14.60 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 24.90% | 25.50% | -0.60 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 14.83% | 2.97% | +11.86 | OGN | /fcf-yield <GO> |
| Operating Margin | — | 34.70% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 3.00% | 28.50% | -25.50 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | -2.90% | 6.00% | -8.90 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.43% | 0.00% | +2.43 | OGN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 5.59 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.4 | 62.1 | -1.70 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.0x | 23.0x | -5.00 | OGN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.63B | $662.49B | -$658.87B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OGN REV | JNJ REV | OGN GROSS % | JNJ GROSS % | OGN FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.22B | $94.19B | 53.3% | 67.9% | $538.0M | $19.70B |
| FY 2024 | $6.40B | $88.82B | 58.0% | 69.1% | $764.0M | $19.84B |
| FY 2023 | $6.26B | $85.16B | — | — | $799.0M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OGN // BETA —
JNJ // BETA 1.08